NASDAQ:SNWV Sanuwave Health Q3 2026 Earnings Results & Report $1.88 +0.03 (+1.62%) Closing price 11/10/2026 04:00 PM EasternExtended Trading$1.96 +0.09 (+4.52%) As of 08:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Sanuwave Health missed analyst expectations on both earnings and revenue in its Q3 2026 results, released November 10, 2026. The company reported EPS of -$0.16 versus the $0.01 consensus estimate, while revenue of $8.58 million fell short of the $13.75 million estimate by $5.17 million. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ3 2026Report DateNovember 10, 2026TimeAfter Market ClosesConference Call DateNovember 11, 2026Conference Call8:30 AM ET Live Call not available Live Event EndedEarnings Conference CallSanuwave Health Q3 202600:00 / 00:00Live Transcript Follow Audio Sanuwave Health EPS ResultsActual EPS-$0.16Consensus EPS $0.01Beat/MissMissed by -$0.17One Year Ago EPSN/AEPS Beat Rate2 of last 6 quartersSanuwave Health Revenue ResultsActual Revenue$8.58 millionExpected Revenue$13.75 millionBeat/MissMissed by -$5.17 millionYoY Revenue GrowthN/AConference Call ResourcesSlide DeckPress Release (8-K)Quarterly Report (10-Q)SEC FilingEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Sanuwave Health Q3 2026 Earnings FAQ Did Sanuwave Health beat earnings estimates for Q3 2026? Sanuwave Health (NASDAQ:SNWV) reported earnings of -$0.16 per share for Q3 2026, missing the consensus estimate of $0.01. The report was announced on Tuesday, November 10, 2026. What was Sanuwave Health's revenue for Q3 2026? Sanuwave Health reported revenue of $8.58 million for Q3 2026, against a consensus estimate of $13.75 million. Sanuwave Health Earnings HeadlinesSanuwave Q3 Revenue Falls 24% to $8.6 MillionNovember 10 at 5:11 PM | quiverquant.comQSanuwave Announces Q3 FY2026 Financial ResultsNovember 10 at 5:00 PM | globenewswire.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 11 at 1:00 AM | Weiss Ratings (Ad)Earnings To Watch: SANUWAVE Health Inc (SNWV) Q3 2026 -- GF Value Sees 886% UpsideNovember 10 at 10:17 AM | finance.yahoo.comSanuwave Will Host a Conference Call on November 11, 2026 at 8:30 AM (ET) to Present Q3 2026 Financial ResultsNovember 6, 2026 | globenewswire.comSanuwave Health Comments on 2027 Medicare Physician Fee Schedule Rate for UltramistNovember 5, 2026 | finance.yahoo.comSee More Sanuwave Health Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Sanuwave Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sanuwave Health and other key companies, straight to your email. Email Address About Sanuwave HealthSanuwave Health (NASDAQ:SNWV), Inc. is a medical technology company focused on regenerative medicine and advanced wound-care solutions. The company develops and commercializes noninvasive devices that use extracorporeal shock wave technology to stimulate biological responses in damaged or difficult-to-heal tissue. Its principal product is the dermaPACE system, which is designed to deliver acoustic shock waves to wound areas, including chronic diabetic foot ulcers. SANUWAVE has also pursued additional applications for its platform in areas such as orthopedic and soft-tissue healing, although the availability and regulatory status of specific products may vary by geography. The company serves the wound-care and regenerative-medicine markets through commercial, clinical, and distribution activities in the United States and international markets. SANUWAVE Health is headquartered in Alpharetta, Georgia. The company’s products and technologies have historically been developed with the aim of providing noninvasive alternatives or complements to conventional treatment for chronic wounds and tissue injuries.View Sanuwave Health ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles The Trade Desk Beats on Revenue, But the Fine Print MattersWhy Kinder Morgan's Chairman Just Bought $15 Million in StockA $4 Billion Jolt: NRG Energy Powers Data Center AmbitionsD-Wave Quantum Has Long-Term Potential, But Is Now the Time to Buy?Archer Aviation's FAA Certificate Is a Milestone, But It Isn't the Final OneRocket Lab's Record Backlog Could Fuel a Rebound, But Neutron Raises the StakesDraftKings Just Lost 20%—And Its Biggest Gamble Is Still Ahead Upcoming Earnings Brookfield (11/12/2026)NU (11/12/2026)Applied Materials (11/12/2026)Cisco Systems (11/12/2026)Mizuho Financial Group (11/13/2026)Mitsubishi UFJ Financial Group (11/13/2026)Sumitomo Mitsui Financial Group (11/13/2026)Home Depot (11/17/2026)Walt Disney (11/17/2026)NVIDIA (11/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
